As of May 31, 2025, Echo Therapeutics Inc (ECTE) reports a Net Margin of -26103.70%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Echo Therapeutics Inc's Net Margin
Over recent years, Echo Therapeutics Inc's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2015-12-31 | -26103.70% |
| 2014-12-31 | -26103.70% |
| 2013-12-31 | -69084.80% |
| 2012-12-31 | -240860.00% |
| 2011-12-31 | -2242.70% |
This slight downward trend highlights how Echo Therapeutics Inc manages its overall profitability and cost control over time.
Comparing Echo Therapeutics Inc's Net Margin to Peers
To better understand Echo Therapeutics Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Echo Therapeutics Inc (ECTE) | -26103.70% |
| PAVmed Inc (PAVM) | 1328.58% |
| United American Healthcare Corp (UAHC) | -23.77% |
| American Medical Technologies Inc (ADLI) | -29.08% |
| DiaSys Corp (DYXC) | -46.78% |
| Remedent Inc (REMI) | -80.63% |
Compared to its competitors, Echo Therapeutics Inc's Net Margin is about average compared to peers, reflecting typical industry profitability.